Protective Role of Boldine Against 5‐Fluorouracil‐Induced Nephrotoxicity: In Vitro and In Vivo Approach
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Rayar Arthina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Hepatology and Molecular Medicine Lab, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical…. Hauptthemen laut MEDLINE: Aporphines, Fluorouracil, Kidney, Kidney Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Drug‐induced nephrotoxicity is a significant clinical complication associated with several chemotherapeutic agents, including 5‐fluorouracil (5‐FU). This study was aimed to investigate the nephroprotective potential of boldine, an aporphine alkaloid, against 5‐FU‐induced renal toxicity using in vitro (HEK293 cells) and in vivo (Wistar rats) models. In vitro cytotoxicity was evaluated using the MTT assay, AO/EB and DAPI staining was performed to identify apoptotic alterations. The expression of apoptotic and antioxidant genes was analyzed by quantitative and semi‐quantitative PCR. For the in vivo study, rats were divided into five groups. One group received a single intraperitoneal dose of 5‐FU (150 mg/kg) to induce nephrotoxicity. In the remaining groups, 5‐FU was administered followed by oral treatment with boldine (10 or 20 mg/kg) or silymarin (100 mg/kg) for 7 days. Biochemical markers including creatinine, urea, blood urea nitrogen, uric acid in serum and oxidative stress indicators in kidney tissue were analyzed. MAPK pathway‐related gene expression and histopathological changes were assessed. Treatment of HEK cells with 5‐FU markedly reduced cell viability and induced apoptosis, while co‐treatment with boldine restored viability and normal cell morphology. Boldine modulated the 5‐FU‐induced downregulation of SOD, CAT, GPx, and Bcl‐2 and upregulation of Bax and caspase‐3. In vivo, boldine treatment normalized elevated nephrotoxic markers in serum, enhanced antioxidant enzyme activities, and inhibited activation of ASK1, ERK1, c‐Jun, and NF‐κB1. Histopathological findings further confirmed that boldine preserved renal tissue integrity and prevented tubular and glomerular damage. Overall, boldine significantly protected against 5‐FU‐induced renal injury via anti‐apoptotic, antioxidant, and anti‐inflammatory mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Hepatology and Molecular Medicine Lab, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
- Department of Biomedical Science, Science Campus, Alagappa University, Karaikudi, Tamil Nadu, India.
ORCID-Profile: Munusamy Karthick, Devaraj Ezhilarasan
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Arthina, R., Karthick, M., Sharmila, M., Sanjay, S., Shree Harini, K., Langeswaran, K., & Ezhilarasan, D. (2025). Protective Role of Boldine Against 5‐Fluorouracil‐Induced Nephrotoxicity: In Vitro and In Vivo Approach. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70636
Vancouver
Arthina R, Karthick M, Sharmila M, Sanjay S, Shree Harini K, Langeswaran K, et al. Protective Role of Boldine Against 5‐Fluorouracil‐Induced Nephrotoxicity: In Vitro and In Vivo Approach. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70636
BibTeX
@article{Arthina2025,
author = {Arthina, Rayar and Karthick, Munusamy and Sharmila, Muthusethupathi and Sanjay, Somasundaram and Shree Harini, Karthik and Langeswaran, Kulanthaivel and Ezhilarasan, Devaraj},
title = {Protective Role of Boldine Against 5‐Fluorouracil‐Induced Nephrotoxicity: In Vitro and In Vivo Approach},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70636}
}
EUVIMED